These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 26852185

  • 1. The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease.
    Del Ben M, Polimeni L, Baratta F, Pastori D, Angelico F.
    Br J Clin Pharmacol; 2017 Jan; 83(1):88-95. PubMed ID: 26852185
    [Abstract] [Full Text] [Related]

  • 2. Dietary Polyphenols and Non-Alcoholic Fatty Liver Disease.
    Abenavoli L, Larussa T, Corea A, Procopio AC, Boccuto L, Dallio M, Federico A, Luzza F.
    Nutrients; 2021 Feb 03; 13(2):. PubMed ID: 33546130
    [Abstract] [Full Text] [Related]

  • 3. Current and Potential Future Pharmacological Approaches for Non- Alcoholic Fatty Liver Disease.
    Imprialos K, Stavropoulos K, Bouloukou S, Kerpiniotis G, Karagiannis A, Doumas M.
    Curr Vasc Pharmacol; 2018 Feb 03; 16(3):276-288. PubMed ID: 28676020
    [Abstract] [Full Text] [Related]

  • 4. Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence.
    Cicero AFG, Colletti A, Bellentani S.
    Nutrients; 2018 Aug 23; 10(9):. PubMed ID: 30142943
    [Abstract] [Full Text] [Related]

  • 5. NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs.
    Caldwell S.
    Clin Mol Hepatol; 2017 Jun 23; 23(2):103-108. PubMed ID: 28494529
    [Abstract] [Full Text] [Related]

  • 6. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y, Sugimoto K, Inui H, Fukusato T.
    World J Gastroenterol; 2015 Apr 07; 21(13):3777-85. PubMed ID: 25852263
    [Abstract] [Full Text] [Related]

  • 7. New Insights into the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Gut-Derived Lipopolysaccharides and Oxidative Stress.
    Ferro D, Baratta F, Pastori D, Cocomello N, Colantoni A, Angelico F, Del Ben M.
    Nutrients; 2020 Sep 10; 12(9):. PubMed ID: 32927776
    [Abstract] [Full Text] [Related]

  • 8. A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model.
    Sangineto M, Bukke VN, Bellanti F, Tamborra R, Moola A, Duda L, Villani R, Romano AD, Serviddio G.
    Nutrients; 2021 Feb 17; 13(2):. PubMed ID: 33671262
    [Abstract] [Full Text] [Related]

  • 9. Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future.
    Barchetta I, Cimini FA, Cavallo MG.
    Nutrients; 2017 Sep 14; 9(9):. PubMed ID: 28906453
    [Abstract] [Full Text] [Related]

  • 10. Novel Action of Carotenoids on Non-Alcoholic Fatty Liver Disease: Macrophage Polarization and Liver Homeostasis.
    Ni Y, Zhuge F, Nagashimada M, Ota T.
    Nutrients; 2016 Jun 24; 8(7):. PubMed ID: 27347998
    [Abstract] [Full Text] [Related]

  • 11. Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives.
    Salomone F, Godos J, Zelber-Sagi S.
    Liver Int; 2016 Jan 24; 36(1):5-20. PubMed ID: 26436447
    [Abstract] [Full Text] [Related]

  • 12. Treatment of Non-Alcoholic Steatosis: Preclinical Study of a New Nutraceutical Multitarget Formulation.
    Micheli L, Pacini A, Di Cesare Mannelli L, Trallori E, D'Ambrosio R, Bianchini C, Lampertico P, Ghelardini C.
    Nutrients; 2020 Jun 18; 12(6):. PubMed ID: 32570937
    [Abstract] [Full Text] [Related]

  • 13. Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis.
    Lirussi F, Azzalini L, Orando S, Orlando R, Angelico F.
    Cochrane Database Syst Rev; 2007 Jan 24; 2007(1):CD004996. PubMed ID: 17253535
    [Abstract] [Full Text] [Related]

  • 14. Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease.
    Vadarlis A, Antza C, Bakaloudi DR, Doundoulakis I, Kalopitas G, Samara M, Dardavessis T, Maris T, Chourdakis M.
    J Gastroenterol Hepatol; 2021 Feb 24; 36(2):311-319. PubMed ID: 32810309
    [Abstract] [Full Text] [Related]

  • 15. Non-Alcoholic Fatty Liver Disease Treatment in Patients with Type 2 Diabetes Mellitus; New Kids on the Block.
    Athyros VG, Polyzos SA, Kountouras J, Katsiki N, Anagnostis P, Doumas M, Mantzoros CS.
    Curr Vasc Pharmacol; 2020 Feb 24; 18(2):172-181. PubMed ID: 30961499
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.
    He XX, Wu XL, Chen RP, Chen C, Liu XG, Wu BJ, Huang ZM.
    PLoS One; 2016 Feb 24; 11(10):e0162368. PubMed ID: 27711128
    [Abstract] [Full Text] [Related]

  • 17. Omega-3 fatty acids as a treatment for non-alcoholic fatty liver disease in children: A systematic review and meta-analysis of randomized controlled trials.
    Chen LH, Wang YF, Xu QH, Chen SS.
    Clin Nutr; 2018 Apr 24; 37(2):516-521. PubMed ID: 28040302
    [Abstract] [Full Text] [Related]

  • 18. Oxidative Stress and Non-Alcoholic Fatty Liver Disease: Effects of Omega-3 Fatty Acid Supplementation.
    Yang J, Fernández-Galilea M, Martínez-Fernández L, González-Muniesa P, Pérez-Chávez A, Martínez JA, Moreno-Aliaga MJ.
    Nutrients; 2019 Apr 18; 11(4):. PubMed ID: 31003450
    [Abstract] [Full Text] [Related]

  • 19. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.
    Faghihzadeh F, Adibi P, Rafiei R, Hekmatdoost A.
    Nutr Res; 2014 Oct 18; 34(10):837-43. PubMed ID: 25311610
    [Abstract] [Full Text] [Related]

  • 20. Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study.
    Abenavoli L, Greco M, Milic N, Accattato F, Foti D, Gulletta E, Luzza F.
    Nutrients; 2017 Aug 12; 9(8):. PubMed ID: 28805669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.